Biomarker panel for early detection of uterine cancer
Uterine cancer is the most prevalent gynecological malignancy in developed and developing countries and its incidence is arising every year. Worldwide, approximately 382,000 new cases are diagnosed each year and there are an estimated 90,000 deaths. As endometrial cancer becomes more prominent, th...
Saved in:
Main Authors: | Nemali Deepthi Deepthi Priya, NANDA KUMAR K V, DEVARAJAPPAGARI BINDU, KASIREDDY LIKHITHA, MEKALA SIVA CHARANI |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2024-10-01
|
Series: | Basic & Clinical Cancer Research |
Subjects: | |
Online Access: | https://bccr.tums.ac.ir/index.php/bccrj/article/view/500 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Primer on the Role of TP53 Mutation and Targeted Therapy in Endometrial Cancer
by: Bohao Zhang, et al.
Published: (2025-01-01) -
The Evaluation of Uterine Sarcomas: Tertiary Center Experience
by: Onur Yavuz, et al.
Published: (2024-08-01) -
Assessment of endometrial carcinoma on biopsy as a predictor of final surgical pathology: Are we doing it right? A completed audit cycle and recommendations
by: Aneeta Jassar, et al.
Published: (2023-07-01) -
Age-related features of some plasminogen activation system components content and activity in the blood of benign and malignant uterine body tumors
by: I. V. Kaplieva, et al.
Published: (2024-09-01) -
To do or not to do? – Endometrial biopsy in younger women with abnormal uterine bleeding
by: Sandra Lynn Jaya-Bodestyne, et al.
Published: (2025-03-01)